I agree that this site is using cookies. You can find further informations here.
X
Guigay, J.
271  results:
Search for persons X
?
1

Two-year Update From CheckMate 141: Outcomes With Nivolumab..:

Ferris, R.L. ; Blumenschein, G.R. ; Fayette, J....
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1317 , 2018
Link: https://doi.org/10.1016/..
 
?
2

Radiothérapie hypofractionnée des cancers ORL chez le sujet..:

Ortholan, C. ; Auperin, A. ; Mertens, C...
Cancer/Radiothérapie.  22 (2018)  6-7 - p. 640-643 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Long-term response in patient with recurrent oropharyngeal ..:

Guigay, J. ; Even, C. ; Mayache-Badis, L....
Oral Oncology.  68 (2017)  - p. 114-118 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Characteristics Of Patients Treated With Cetuximab-Based Ex..:

Guigay, J ; Chamorey, E ; van Hille, B..
Value in Health.  20 (2017)  9 - p. A462 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Biomarkers predict enhanced clinical outcomes with afatinib..:

Cohen, E.E.W. ; Licitra, L.F. ; Burtness, B....
Annals of Oncology.  28 (2017)  10 - p. 2526-2532 , 2017
Link: https://doi.org/10.1093/..
 
?
6

Histologically Proven Bronchial Neuroendocrine Tumors in ME..:

Lecomte, P. ; Binquet, C. ; Le Bras, M....
World Journal of Surgery.  42 (2017)  1 - p. 143-152 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Réirradiation des cancers des voies aérodigestives supérieu..:

Doyen, J. ; Lam Cham Kee, D. ; Krebs, L....
Cancer/Radiothérapie.  21 (2017)  6-7 - p. 521-526 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Tumor Biomarker Association With Clinical Outcomes in Recur..:

Cohen, E. ; Licitra, L. ; Burtness, B....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 868-869 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Afatinib versus methotrexate in older patients with second-..:

Clement, P.M. ; Gauler, T. ; Machiels, J.P....
Annals of Oncology.  27 (2016)  8 - p. 1585-1593 , 2016
Link: https://doi.org/10.1093/..
 
?
10

Evaluation of the combination of oxaliplatin and 5-fluorour..:

Walter, T. ; Planchard, D. ; Bouledrak, K....
Lung Cancer.  96 (2016)  - p. 68-73 , 2016
Link: https://doi.org/10.1016/..
 
?
11

SP-0409: Immunotherapy for HNSCC: an emerging paradigm?:

Guigay, J.
Radiotherapy and Oncology.  119 (2016)  - p. S190-S191 , 2016
Link: https://doi.org/10.1016/..
 
?
12

French Society of ENT (SFORL) guidelines for care pathway o..:

Cuny, F. ; Babin, E. ; Lacau-Saint-Guily, J....
European Annals of Otorhinolaryngology, Head and Neck Diseases.  132 (2015)  4 - p. 205-208 , 2015
Link: https://doi.org/10.1016/..
 
?
13

OC-005: Afatinib versus methotrexate in recurrent/metastati..:

Clement, P. ; Gauler, T. ; Machiels, J.P.H....
Radiotherapy and Oncology.  114 (2015)  - p. 7-8 , 2015
Link: https://doi.org/10.1016/..
 
?
14

PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-C..:

Guigay, J. ; Keilholz, U. ; Mesia, R....
Radiotherapy and Oncology.  114 (2015)  - p. 46 , 2015
Link: https://doi.org/10.1016/..
 
?
15

2800 Cabazitaxel in patients with refractory recurrent or m..:

Fayette, J. ; Guigay, J. ; Letourneau, C....
European Journal of Cancer.  51 (2015)  - p. S557 , 2015
Link: https://doi.org/10.1016/..
 
1-15